Given that approximately 90% of the CD19+ B cells express CD5, additional co‐staining for this CLL‐associated marker was omitted in subsequent experiments (Supporting Information S1: Figure 1A). Here, CD19 is linked to B-cell chronic lymphocytic leukemia.